The probability of HLA-C matching between patient and unrelated donor at the molecular level: Estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles

Transplantation

Volumn 68, Issue 7, 1999, Pages 1044-1050

  Prasad, Vinod K ^a   Heller, Glenn ^a   Kernan, Nancy A ^a   O'Reilly, Richard J ^a   Yang, Soo Young ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; HLA MATCHING; HLA SYSTEM; HUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROBABILITY;

ALLELES; BONE MARROW TRANSPLANTATION; DNA; GENE FREQUENCY; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMERASE CHAIN REACTION; PROBABILITY; TISSUE DONORS;

EID: 0033569846     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00024     Document Type: Article

References (40)

1. Beatty PG, Dahlberg S, Mickelson EM, et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45(4): 714.
2. Schipper RF, D'Amaro J, Oudshoorn M. The probability of finding a suitable related donor for bone marrow transplantation in extended families [see Comments]. Blood 1996; 87(2): 800.
3. Dupont B. Immunology of hematopoietic stem cell transplantation: a brief review of its history. Immunol Rev 1997; 157: 5.
4. Hansen JA, Petersdorf E, Martin PJ, Anasetti C. Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 1997; 157: 141.
5. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15(5): 1767.
6. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations From unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328(9): 593.
7. Anasetti C, Beatty PG, Storb R, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29(2): 79.
8. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86(10): 3979.
9. Freytes CO, Beatty PG. Representation of Hispanics in the National Marrow Donor Program. Bone Marrow Transplant 1996; 17(3): 323.
10. Perkins HA, Hansen JA. The U.S. National Marrow Donor Program. Am J Pediatr Hematol Oncol 1994; 16(1): 30.
11. Downie TR, Hows JM, Gore SM, Bradley BA, Howard MR. A survey of use of unrelated volunteer donor bone marrow transplantation at 46 centers worldwide, 1989-93: International Marrow Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant 1995; 15(4): 499.
12. Speiser DE, Tiercy JM, Rufer N, et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996; 87(10): 4455.
13. Nademanee A, Schmidt GM, Parker P, et al. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 1995; 86(3): 1228.
14. Ottinger H, Grosse-Wilde M, Schmitz A, Grosse-Wilde H. Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 1994; 14 (Suppl 4): S34.
15. Anasetti C, Etzioni R, Petersdorf EW, Martin PJ, Hansen JA. Marrow transplantation from unrelated volunteer donors. Annu Rev Med 1995; 46: 169.
16. Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY. DNA typing for HLA-A and -B identifies disparities between patients and unrelated donors matched by HLA-A and -B serology and DRB1. Blood 1999; 93(1): 399.
17. Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci: Biol Blood Marrow Transplant 1999; 5(2): 77.
18. Fleischhauer K, Kernan NA, RJ OR, Dupont B, Yang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990; 323(26): 1818.
19. Petersdorf EW, Longton GM, Anasetti C, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89(5): 1818.
20. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339(17): 1177.
21. Barnardo MC, Davey NJ, Bunce M, et al. A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 1996; 61(9): 1420.
22. Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 1995; 2(2): 167.
23. van der Bruggen P, Szikora JP, Boel P, et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw* 1601. Eur J Immunol 1994; 24(9): 2134.
24. Schendel DJ, Reinhardt C, Nelson PJ, et al. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting selfpeptides. J Immunol 1992; 149(7): 2406.
25. Colonna M, Spies T, Strominger JL, et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 1992; 89(17): 7983.
26. Moretta A, Sivori S, Vitale M, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995; 182(3): 875.
27. Biassoni R, Cantoni C, Falco M, et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996; 183(2): 645.
28. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993; 90(24): 12000.
29. Biassoni R, Falco M, Cambiaggi A, et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995; 182(2): 605.
30. Hansen TH, Carreno BM, Sachs DH. The major histocompatibility complex. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1993: 577.
31. Mayr WR. HLA-A, B, C gene and haplotype frequencies in Vienna: an analysis of family data. Hum Genet 1977; 37(1): 41.
32. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies of HLA and complement loci in various ethnic groups. In: Tsuzi K, Aizawa M, Sasazuki T, eds. Eleventh Histocompatibility Workshop and Conference, vol 1. Yokohoma, Japan: Oxford University Press, 1991: 1065.
33. Prasad VK, Yang SY. Allele assignment for HLA-A, -B, and -C genes to the Tenth International Histocompatibility Workshop cell lines. Tissue Antigens 1996; 47(6): 538.
34. Cereb N, Yang SY. Dimorphic primers derived from intron 1 for use in the molecular typing of HLA-B alleles. Tissue Antigens 1997; 50(1): 74.
35. Ng J, Hurley CK, Carter C. et al. Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2. Tissue Antigens 1996; 47(1): 21.
36. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995; 46(1): 1.
37. Zelterman D. Goodness-of-fit tests for large sparse multinomial distributions. J Am Stat Assoc 1987; 82(398): 624.
38. Bishara A, Amar A, Brautbar C. Condiotti R, Lazarovitz V, Nagler A. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol. 1995; 23(14): 1667.
39. Chapman JR, Taylor C, Ting A, Morris PJ. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986; 42(1): 91.
40. Bunce M, Barnardo MC, Procter J, Marsh SG, Vilches C, Welsh KI. High resolution HLA-C typing by PCR-SSOP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 1996; 48(6): 680.